B. Christopher Kim

B. Kim is a seasoned professional in the field of life sciences venture capital investment on a global scale.

With a strong educational background, B. Kim holds a BS in Biology from the University of California, Irvine, an MBA from Carnegie Mellon University - Tepper School of Business, and a PhD from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.

Currently, B. Kim serves as the Managing Director at Novatio Ventures, bringing a wealth of experience and expertise to the role.

Throughout B. Kim's career, they have held various key positions in reputable organizations such as BaseLaunch, Chong Kun Dang Pharm, CytoReason, and Bridge Biotherapeutics, Inc.

Additionally, B. Kim has been involved in founding and contributing to organizations like The Korea-Seoul Life Science Fund (KSLSF), PharmAbcine Inc., and Oxford Bioscience Partners.

Prior to their current role, B. Kim gained valuable experience as the Associate Director of Operations, Strategy, and Corporate Development at Novartis Institutes for BioMedical Research (NIBR), further solidifying their expertise in the industry.

Having also worked at IBM as an Extreme Blue Associate and conducted research at institutions like MD Anderson Cancer Center and Alkermes, B. Kim's career journey is marked by a strong commitment to the life sciences and biotechnology sectors.